HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$3.43
Day range
$3.24 - $3.48
Year range
$3.21 - $236.94
Market cap
2.28M USD
Avg Volume
91.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.17M | -59.22% |
Net income | -2.32M | 56.20% |
Net profit margin | — | — |
Earnings per share | -5.28 | 99.76% |
EBITDA | -2.15M | 59.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.88M | -74.83% |
Total assets | 3.94M | -61.52% |
Total liabilities | 2.28M | -60.54% |
Total equity | 1.65M | — |
Shares outstanding | 523.20K | — |
Price to book | 1.09 | — |
Return on assets | -123.59% | — |
Return on capital | -322.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.32M | 56.20% |
Cash from operations | -3.91M | -11.60% |
Cash from investing | -12.87K | -179.42% |
Cash from financing | 2.45M | -66.89% |
Net change in cash | -1.48M | -138.11% |
Free cash flow | -2.89M | -66.69% |
About
Founded
2016
Headquarters
Website
Employees
8
